|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/396 | |||
| A61K 31/407 | |||
| A61K 33/24 | |||
| C07D 203/14 | |||
| C07D 403/10 |
| (11) | Number of the document | 2882743 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13742640.9 |
| Date of filing the European patent application | 2013-07-30 | |
| (97) | Date of publication of the European application | 2015-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/065968 |
| Date | 2013-07-30 |
| (87) | Number | WO 2014/020012 |
| Date | 2014-02-06 |
| (30) | Number | Date | Country code |
| 201213486 | 2012-07-30 | GB |
| (72) |
MCGOWN, Alan, GB
HADFIELD, John, GB
BUTLER, John, GB
|
| (73) |
Onco-NX Limited,
76 King Street, Manchester M2 4NH,
GB
|
| (54) | QUINONE COMPOUNDS AND THEIR USES FOR THE TREATMENT OF CANCER |
| QUINONE COMPOUNDS AND THEIR USES FOR THE TREATMENT OF CANCER |